Am. Gray et Jh. Connick, Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism, EUR J PHARM, 362(2-3), 1998, pp. 127-136
The effect of the muscarinic antagonist, scopolamine, was examined for a ch
ange in the increase in extracellular dopamine, dihydroxyphenyl acetic acid
(DOPAC), homovanillic acid (HVA) and 5-hydroxyindolacetic acid (5-HIAA), i
nduced by haloperidol or clozapine in the striatum and nucleus accumbens of
anaesthetised and awake rats,:monitored using in vivo cerebral microdialys
is. Rats received scopolamine (1 mg kg(-1); s.c.) or vehicle followed by ha
loperidol (1 mg kg(-1); s.c.) or clozapine (20 mg kg(-1); s.c.). Dopamine,
DOPAC, HVA and 5-HIAA overflow into striatal or accumbens perfusates was de
termined using high performance liquid chromatography with electrochemical
detection (HPLC-ECD). Scopolamine failed to modify the clozapine- or halope
ridol-induced efflux of dopamine or its metabolites in either the striatum
or nucleus accumbens following systemic administration in anaesthetised or
awake rats. Although pretreatment with scopolamine tended to produce a smal
ler increase in the clozapine-induced efflux of DOPAC in striatal perfusate
s than following clozapine treatment alone, this was not statistically sign
ificant. Furthermore, local infusion of scopolamine (100 mu M) with clozapi
ne (1 mM) via the microdialysis probe did not attenuate the elevated efflux
of dopamine observed following clozapine alone, in either the striatum or
nucleus accumbens, in anaesthetised rats. This treatment did prevent the cl
ozapine-induced increase in DOPAC and HVA in the striatum but not the nucle
us accumbens. Carbachol (50 mu M) infused into the dorsolateral striatum or
nucleus accumbens raised extracellular dopamine levels 200% and 150%, resp
ectively above baseline. Our data suggest that the increased efflux of dopa
mine and its metabolites in the rat basal ganglia following clozapine admin
istration is not significantly dependent upon the interaction of clozapine
with muscarinic receptors. (C) 1998 Elsevier Science B.V. All rights reserv
ed.